Medicines of limited clinical value

NHS England updated its policy guidance (in August 2023) on items which should not routinely be prescribed in primary care, because they are unsafe, ineffective for some for or all patients, or are not cost effective. The policy recommendation are grouped under two categories:

Items where no prescribing is appropriate (no exceptions apply)

Co-proxamol

Glucosamine and Chondroitin

Herbal Treatments and Homeopathy

Minocycline for Acne

Omega-3 Fatty Acid Compounds

Silk Garments

Items where prescribing may be appropriate in some exceptional circumstances

Aliskiren

Amiodarone

Bath and Shower Preparations

Dosulepin

Doxazosin Modified Release

Dronedarone

Fentanyl Immediate Release

Lidocaine Plasters

Liothyronine

Lutein and Antioxidants

Insulin Needles for pre-filled and reusable insulin pens

Oxycodone and Naloxone Combination Products (Taringact®)

Paracetamol and Tramadol Combination Products (Tramacet®)

Perindopril Arginine

Rubefacients (excluding topical non-steroidal anti-inflammatory drugs and capsaicin)

Travel Vaccines

Trimipramine